Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
A law passed in 2011 required food companies to track food in the event of contamination and a recall. The administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback